Latest News
Using Microdosing to Enhance Development of anti-infectives- Gen Eng News Nov 2008
Date Posted: |
05 Nov 2008 |
Summary: |
Early Availability of PK Information Allows for Selection of Potentially Promising Molecules
|
|
"For a biotech company seeking to discover and develop novel drugs, microdosing offers an opportunity to reduce risk, cost, and the time required to confirm acceptable pharmacokinetics (PK) in man."
Please follow the link on the picture below to see the full article.
For examples of Xceleron studies with anti-infectives, please follow this link.
Click to see more news
